Alain Schaffter

Alain Schaffter started his career as an auditor at PricewaterhouseCoopers. In 2010, he moved into the pharmaceutical industry and became Head Group Finance of the listed Acino Group before joining Polyphor, a Basel-based biotech company, as CFO in 2016.

In early 2018, he started to work as a consultant for several companies in the Life Science Industry, supporting them in specific projects like Reporting, IFRS conversion or IPO preparation before he became Head Special Finance Projects at Solvias AG in August 2018. There he ran and coordinated the due diligence and deal related activities for the sale of Solvias Group to two Healthcare Investors, including process optimization in the areas of Accounting, Tax and Reporting. After completion of the transaction in June 2020, Alain Schaffter assumed, in addition to his existing role, the role as Head Finance M&A but also as CFO on an ad interim basis.

He served also as a Member of Group Executive Committees and held various mandates as Chairman of the Board of Trustees and as a member of the Board of Directors, of the Management Board and of the Audit Committee at subsidiaries worldwide.

Alain Schaffter holds a degree as a Swiss certified public accountant as well as a Federal certificate of higher vocational education and training for fiduciaries.